IUPAC/Chemical Name
3-Chloro-5-phenylsalicylic acid
InChi Key
RJMZIUFNDNYWDU-UHFFFAOYSA-N
InChi Code
InChI=1S/C13H9ClO3/c14-11-7-9(8-4-2-1-3-5-8)6-10(12(11)15)13(16)17/h1-7,15H,(H,16,17)
SMILES Code
OC1=C(Cl)C=C(C2=CC=CC=C2)C=C1C(O)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
248.66
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Siegel SD, Liu J, Ton-That H. Biogenesis of the Gram-positive bacterial cell envelope. Curr Opin Microbiol. 2016 Dec;34:31-37. doi: 10.1016/j.mib.2016.07.015. Epub 2016 Aug 4. Review. PubMed PMID: 27497053; PubMed Central PMCID: PMC5164837.
2: Bradley LA, Palomaki GE, Gutman S, Samson D, Aronson N. Comparative effectiveness review: prostate cancer antigen 3 testing for the diagnosis and management of prostate cancer. J Urol. 2013 Aug;190(2):389-98. doi: 10.1016/j.juro.2013.02.005. Epub 2013 Mar 29. Review. PubMed PMID: 23545099.
3: Shan L. (125)I-Labeled monoclonal antibody PSA30. 2012 Nov 9 [updated 2012 Dec 5]. Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. Available from http://www.ncbi.nlm.nih.gov/books/NBK114649/ PubMed PMID: 23236644.
4: Benchikh El Fegoun A, Villers A. [Molecular forms of PSA]. Prog Urol. 2007 Apr;17(2):165-71. Review. French. PubMed PMID: 17489311.
5: Roddam AW, Duffy MJ, Hamdy FC, Ward AM, Patnick J, Price CP, Rimmer J, Sturgeon C, White P, Allen NE; NHS Prostate Cancer Risk Management Programme. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis. Eur Urol. 2005 Sep;48(3):386-99; discussion 398-9. Review. PubMed PMID: 15982797.
6: Naya Y, Okihara K. Role of complexed PSA in the early detection of prostate cancer. J Natl Compr Canc Netw. 2004 May;2(3):209-12. Review. PubMed PMID: 19795605.
7: Gretzer MB, Partin AW. PSA markers in prostate cancer detection. Urol Clin North Am. 2003 Nov;30(4):677-86. Review. PubMed PMID: 14680307.
8: Mikolajczyk SD, Rittenhouse HG. Pro PSA: a more cancer specific form of prostate specific antigen for the early detection of prostate cancer. Keio J Med. 2003 Jun;52(2):86-91. Review. PubMed PMID: 12862359.
9: Brawer MK. Clinical usefulness of assays for complexed prostate-specific antigen. Urol Clin North Am. 2002 Feb;29(1):193-203, xi. Review. PubMed PMID: 12109345.
10: Okihara K, Babaian RJ. Complexed prostate-specific antigen improvement in detecting prostate cancer. Curr Urol Rep. 2001 Jun;2(3):253-8. Review. PubMed PMID: 12084274.
11: Lein M, Stephan C, Jung K, Schnorr D, Loening SA. [Molecular forms of prostate-specific antigen and human kallikrein 2 as possible indicators in prostatic carcinoma diagnosis]. Urologe A. 2000 Jul;39(4):313-23. Review. German. PubMed PMID: 10957772.
